Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4C | Q9H3R0 | 6/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.52 |
| ▸ | MEN1 | O00255 | 2/20 | 0.52 |
| ▸ | MAPT | P10636 | 2/20 | 0.52 |
| ▸ | KDM6B | O15054 | 2/20 | 0.52 |
| ▸ | KDM4D | Q6B0I6 | 2/20 | 0.52 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.52 |
| ▸ | KDM4A | O75164 | 1/20 | 0.52 |
| ▸ | THRB | P10828 | 1/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.52 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | DTYMK | P23919 | 1/20 | 0.45 |
| ▸ | ASPH | Q12797 | 1/20 | 0.43 |
| ▸ | KDM8 | Q8N371 | 1/20 | 0.43 |
| ▸ | HTT | P42858 | 2/20 | 0.43 |
| ▸ | RAB9A | P51151 | 1/20 | 0.43 |
| ▸ | GAA | P10253 | 1/20 | 0.43 |
| ▸ | NCOA1 | Q15788 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1231890 | 1.00 | KDM4C (0.52) | KDM4CALDH1A1KMT2AKDM4EMEN1 | |
| SCHEMBL6221966 | 0.87 | DTYMK (0.50) | KDM4CALDH1A1KMT2AKDM4EMEN1 | |
| SCHEMBL12672297 | 0.84 | HTT (0.45) | ALDH1A1KMT2AKDM4EMEN1MAPT | |
| SCHEMBL11718666 | 0.84 | TDP1 (0.49) | KDM4CALDH1A1KMT2AKDM4EMEN1 | |
| SCHEMBL1229622 | 0.80 | HTT (0.49) | KDM4CALDH1A1KDM4EMAPTL3MBTL1 | |
| SCHEMBL12672298 | 0.80 | GSK3B (0.44) | ALDH1A1KMT2AKDM4EMEN1MAPT | |
| SCHEMBL318319 | 0.80 | HTT (0.42) | ALDH1A1KMT2AKDM4EMEN1MAPT | |
| SCHEMBL2747914 | 0.80 | ALDH1A1 (0.57) | ALDH1A1KMT2AKDM4EMAPTL3MBTL1 | |
| SCHEMBL11722037 | 0.80 | KMT2A (0.47) | ALDH1A1KMT2AKDM4EMEN1MAPT | |
| SCHEMBL27699031 | 0.79 | ALDH1A1 (0.41) | ALDH1A1KMT2AMEN1MAPTL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118420919-A | Metal organic framework material with trivalent boron blocked Lewis acid-base pair with fixed structures at two ends, preparation method and application thereof | 武汉大学 | 2024-08-02 | — | — | CN | claimed |
| CN-115557886-A | Synthetic method of 3-nitroisonicotinic acid methyl ester | 山西永津集团有限公司 | 2023-01-03 | — | — | CN | claimed |
| WO-2025202010-A1 | USE OF A COMPOSITION AND A PROCESS FOR SELECTIVELY ETCHING SILICON | BASF SE (DE) | 2025-10-02 | — | — | WO | disclosed |
| CN-118420919-A | Metal organic framework material with trivalent boron blocked Lewis acid-base pair with fixed structures at two ends, preparation method and application thereof | 武汉大学 | 2024-08-02 | — | — | CN | disclosed |
| CN-115650906-A | Preparation method of 2-aminoisonicotinic acid | 苏州艾缇克药物化学有限公司 | 2023-01-31 | — | — | CN | disclosed |
| CN-115557886-A | Synthetic method of 3-nitroisonicotinic acid methyl ester | 山西永津集团有限公司 | 2023-01-03 | — | — | CN | disclosed |
| CN-115557886-A | Synthetic method of 3-nitroisonicotinic acid methyl ester | 山西永津集团有限公司 | 2023-01-03 | — | — | CN | disclosed |
| US-8586623-B2 | 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses | UCB PHARMA, S.A. (BE) | 2013-11-19 | — | — | US | disclosed |
| US-8518943-B2 | 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses | UCB PHARMA, S.A. (BE) | 2013-08-27 | — | — | US | disclosed |
| US-20120214815-A1 | 2-Oxo-1-Pyrrolidine Derivatives, Processes for Preparing Them and Their Uses | UCB PHARMA, S.A. (BE) | 2012-08-23 | — | — | US | disclosed |
| US-20120196866-A1 | 2-Oxo-1-Pyrrolidine Derivatives, Processes for Preparing Them and Their Uses | UCB PHARMA, S.A. (BE) | 2012-08-02 | — | — | US | disclosed |
| US-8183241-B2 | 2-oxo-1-pyrrolidine derivatives | UCB PHARMA, S.A. (BE) | 2012-05-22 | — | — | US | disclosed |
| US-20090156607-A1 | 2-OXO-1-PYRROLIDINE DERIVATIVES | UCB, S.A. (BE) | 2009-06-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120214815-A1 | 2-Oxo-1-Pyrrolidine Derivatives, Processes for Preparing Them and Their Uses | CYP3A4, CYP1B1, CYP2D6 | KDM4C 1614/4885ALDH1A1 560/4885KMT2A 3901/4885 |
| US-20120196866-A1 | 2-Oxo-1-Pyrrolidine Derivatives, Processes for Preparing Them and Their Uses | CYP3A4, CYP1B1, CYP2D6 | KDM4C 1614/4885ALDH1A1 560/4885KMT2A 3901/4885 |
| US-20090156607-A1 | 2-OXO-1-PYRROLIDINE DERIVATIVES | OPRD1, PPOX, CYP2D6 | KDM4C 1773/4885ALDH1A1 447/4885KMT2A 3761/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.